Data as of Jul 22
| +0.06 / +1.78%|
The 2 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +133.24% increase from the last price of 3.43.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.